Page 4 - Zyme Communications News Today

Key appointment forms part of ongoing plans to strengthen senior leadership team and support expansion of microfluidic product range for single cell analysis Sphere Fluidics, a company developing

Antigen designed to support immunoassay and vaccine development applications The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world's leading suppliers of reagents that enables

Research targeted at identifying novel inhibitors or activators of Kv3.1 mutation Metrion Biosciences Limited ("Metrion"), the specialist ion channel contract research and drug discovery company,

Single analyte biomarker kit reagents introduced for the quantification of five human inflammatory cytokines First kits available in expanding offering to support biomarker studies Gyros

Appointments of Business Development Manager and Senior Product Manager follow move to state-of-the-art new facilities at Oxford Technology Park Expansion of team will support over 30 new

Investegate announcements from Avacta Group PLC, Director/PDMR Shareholding

Investment in purpose-built facilities supports ongoing recruitment and growth in new product development activities First phase of new facility doubles overall space capacity, with view to

Investegate announcements from Avacta Group PLC, Posting of the Companys Open Offer Circular

Investegate announcements from Avacta Group PLC, Director/PDMR Shareholding

Investegate announcements from Avacta Group PLC, Admission of the Companys Ordinary Shares